Release Date: 10/05/11 11:24 Summary: Unaudited Interim Financial Report Price Sensitive: No Download Document 92.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%